Drugmakers Point Finger at Middlemen for Rising Drug Prices – Wall Street Journal
Wall Street Journal |
Drugmakers Point Finger at Middlemen for Rising Drug Prices
Wall Street Journal As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced. Some of the sharpest criticism has come from drug-industry executives who have been grilled by … Insider Q&A: A front-row seat for the drug pricing battleU.S. News & World Report |